-
$149.00
A triple-growth hormone peptide stack: CJC-1295 (12mg), Tesamorelin (3mg), and Ipamorelin (3mg). Designed for advanced research focused on GH release, fat metabolism, recovery, and regenerative pathways.
-
$100.00
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been primarily studied for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution. Beyond this, ongoing research is exploring Tesamorelin’s potential to support peripheral nerve health, reduce fat mass, and slow the progression of mild cognitive impairment. These emerging applications suggest broader therapeutic value for Tesamorelin beyond its initial indication.
-
$150.00
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been primarily studied for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution. Beyond this, ongoing research is exploring Tesamorelin’s potential to support peripheral nerve health, reduce fat mass, and slow the progression of mild cognitive impairment. These emerging applications suggest broader therapeutic value for Tesamorelin beyond its initial indication.
-
$75.00
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has been primarily studied for the treatment of HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution. Beyond this, ongoing research is exploring Tesamorelin’s potential to support peripheral nerve health, reduce fat mass, and slow the progression of mild cognitive impairment. These emerging applications suggest broader therapeutic value for Tesamorelin beyond its initial indication.
